Befloxatone, a Spontaneously Reversible MAO-A Inhibitor: Modelisation at Molecular Level

Jean-Jacques Koenig; Florence Moureau; Daniel Vercauteren; François Durant; Fiona Ducrey; François-Xavier Jarreau

Befloxatone, a Spontaneously Reversible MAO-A Inhibitor: Modelisation at Molecular Level

Jean-Jacques Koenig, Florence Moureau, Daniel Vercauteren, François Durant, Fiona Ducrey, François-Xavier Jarreau

Résultats de recherche: Contribution à un journal/une revue › Article › Revue par des pairs

langue originale	Anglais
Pages (de - à)	424B
Nombre de pages	1
journal	Clinical neuropharmacology
Volume	15
Numéro de publication	Part B
Etat de la publication	Publié - 1992

Contient cette citation

@article{c68dc542f1e342e99dc55d1f5fcb80ba,

title = "Befloxatone, a Spontaneously Reversible MAO-A Inhibitor: Modelisation at Molecular Level",

author = "Jean-Jacques Koenig and Florence Moureau and Daniel Vercauteren and Fran{\c c}ois Durant and Fiona Ducrey and Fran{\c c}ois-Xavier Jarreau",

year = "1992",

language = "English",

volume = "15",

pages = "424B",

journal = " Clinical neuropharmacology",

issn = "1537-162X",

publisher = "Raven press",

number = "Part B",

}

TY - JOUR

T1 - Befloxatone, a Spontaneously Reversible MAO-A Inhibitor: Modelisation at Molecular Level

AU - Koenig, Jean-Jacques

AU - Moureau, Florence

AU - Vercauteren, Daniel

AU - Durant, François

AU - Ducrey, Fiona

AU - Jarreau, François-Xavier

PY - 1992

Y1 - 1992

M3 - Article

SN - 1537-162X

VL - 15

SP - 424B

JO - Clinical neuropharmacology

JF - Clinical neuropharmacology

IS - Part B

ER -